Evidence map›Paper›PMID 41872953›Full record

ArticleCell & bioscience2026

Regulation of oncogenic C-terminal truncated p53β protein isoform expression by SRSF3-UPF1 splicing and surveillance axis.

Jiwon Jeong, Dawon Hong, Tae Young Park, Jung Hur, Taeyoung Koo, Sunjoo Jeong

Erratum issuedAbstract read
In one paragraph

Article in Cell & bioscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Jiwon Jeong *Laboratory of RNA Cell Biology, Center for Next Generation RNA Editing, Graduate Department of Bioconvergence Science and Technology, Dankook University, Yongin, Republic of Korea.
Dawon Hong *Laboratory of RNA Cell Biology, Center for Next Generation RNA Editing, Graduate Department of Bioconvergence Science and Technology, Dankook University, Yongin, Republic of Korea.
Tae Young ParkLaboratory of RNA Cell Biology, Center for Next Generation RNA Editing, Graduate Department of Bioconvergence Science and Technology, Dankook University, Yongin, Republic of Korea.
Jung HurLaboratory of RNA Cell Biology, Center for Next Generation RNA Editing, Graduate Department of Bioconvergence Science and Technology, Dankook University, Yongin, Republic of Korea.
Taeyoung KooDepartment of Pharmaceutical Sciences, College of Pharmacy, Kyung Hee University, Seoul, Republic of Korea.
Sunjoo JeongLaboratory of RNA Cell Biology, Center for Next Generation RNA Editing, Graduate Department of Bioconvergence Science and Technology, Dankook University, Yongin, Republic of Korea. sjsj@dankook.ac.kr.ORCID http://orcid.org/0000-0001-5519-5587

Funding

National Research Foundation of Korea RS-2025-02214538National Research Foundation of Korea (NRF) RS-2023-00208597Samsung Science and Technology Foundation SSTF-BA1601-16
6 · The paper itself

Abstract

Dysregulated expression of tumor suppressor genes can impair their functions, even promoting oncogenesis. Expression of p53β mRNA can be regulated by alternative splicing and RNA surveillance, otherwise translated to a C-terminal truncated p53 protein with a unique neoepitope. Here, we identified that p53 introns bear the binding sites for serine and arginine-rich splicing factor 3 (SRSF3). SRSF3 binding to p53 intron 9 facilitates upstream frameshift 1 (UPF1) recruitment and regulates production of p53β mRNA. We also demonstrated that this ternary ribonucleoprotein complex forms cotranscriptionally in chromatin. SRSF3 depletion disrupts SRSF3-UPF1 axis, elevating the levels of p53β mRNA encoding a C-terminal-truncated isoform. Intriguitly, p53β protein isoform lacks tumor-suppressive activity and promotes oncogenic epithelial-mesenchymal transition through enhanced cell migration and invasion. We define the coordinated roles of the splicing factor SRSF3 and the RNA surveillance factor UPF1 in regulating p53 mRNA isoform expression, thereby linking splicing fidelity with RNA surveillance during transcription. Our findings highlight the SRSF3-UPF1 axis for preventing oncogenic p53β protein isoform accumulation, offering a potential therapeutic target to restore p53 function and impede cancer progression.

Indexed as

Alternative splicingCancerIntron retentionp53 mRNA isoformsSRSF3

Identifiers

PMID41872953
PMCPMC13130618

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.